NCT06893055 Strength-Endurance Circuit Training in Parkinson's Disease
| NCT ID | NCT06893055 |
| Status | Recruiting |
| Phase | — |
| Sponsor | General University Hospital, Prague |
| Condition | Parkinson Disease, Idiopathic |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2025-03-03 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2025-03-03 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to determine whether adding strength training to aerobic training has a comparable or greater effect on the clinical status of Parkinson's disease patients than a standalone aerobic training. \- Does combined strength-endurance circuit training provide added benefits to physical performance, disease severity, blood biomarkers, and quality of life in PD patients compared to standalone aerobic training? Participants will: * undergo outcome measurements before and after the 12-week intervention and a 3-month follow-up measurement, * visit the clinic twice a week for 1-hour training sessions. * selected patients will be given a smartwatch with a pedometer that will count their average number of steps before, during and after the training period
Eligibility Criteria
Inclusion Criteria: * age ≥18 years * diagnosis of idiopathic Parkinson´s disease * Hoehn-Yahr Scale ≤ 2,5 * stable dopaminergic medication Exclusion Criteria: * age ≥75 years * Hoehn-Yahr Scale ≥ 2,5 * deep brain stimulation * presence of freezing * Camptocormia * inability to walk without support * inability to perform study procedures * limiting co-morbidities * attendance at training sessions below 70%
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06893055 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Parkinson Disease, Idiopathic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06893055 currently recruiting?
Yes, NCT06893055 is actively recruiting participants. Contact the research team at jakub.vitek@vfn.cz for enrollment information.
Where is the NCT06893055 trial being conducted?
This trial is being conducted at Prague, Czechia.
Who is sponsoring the NCT06893055 clinical trial?
NCT06893055 is sponsored by General University Hospital, Prague. The trial plans to enroll 90 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.